Methodologies for synthesis of transcription inhibiting peptides, amatoxins, and their bioconjugates for targeted cancer therapy
A Pryyma - 2022 - open.library.ubc.ca
This thesis describes my contribution to the development of synthetic methods directed at
accessing bicyclic toxic peptides, amatoxins, as well as amatoxin-based bioconjugates for …
accessing bicyclic toxic peptides, amatoxins, as well as amatoxin-based bioconjugates for …
Recent advances on nanotechnology applications to cancer drug therapy
One of the greatest challenges in cancer drug therapy is to maximize the effectiveness of the
active ingredient while reducing its systemic adverse effects. Conventional (non-targeted) …
active ingredient while reducing its systemic adverse effects. Conventional (non-targeted) …
Mercaptoalkanol-derived self-immolative linkers for bioconjugates. Synthesis and analysis
M Sengee - 2021 - munin.uit.no
Many of the anticancer compounds discovered through synthesis or bioprospecting activities
are found to be equally toxic to healthy cells and tumors. Consequently, these compounds …
are found to be equally toxic to healthy cells and tumors. Consequently, these compounds …
[PDF][PDF] Modulowanie właściwości peptydów penetrujących do komórek
W Lipiński, B Kolesińska - Wiadomości Chemiczne, 2017 - bibliotekanauki.pl
Wojciech Lipiński*, Beata Kolesińska Page 1 2017, 71, 9-10 MODULOWANIE
WŁAŚCIWOŚCI PEPTYDÓW PENETRUJĄCYCH DO KOMÓREK MODULATING …
WŁAŚCIWOŚCI PEPTYDÓW PENETRUJĄCYCH DO KOMÓREK MODULATING …
[PDF][PDF] Intracellular delivery of therapeutic antibodies
GS Hackett - 2012 - core.ac.uk
Therapeutic antibodies are highly versatile macromolecules that can be engineered to bind
and inhibit a target with high specificity. Unfortunately, the cell membrane is impenetrable to …
and inhibit a target with high specificity. Unfortunately, the cell membrane is impenetrable to …
Peptide conjugates of cytotoxins as therapeutics
DR Marshall, JM CSENGERY, RJ Maguire… - 2021 - Google Patents
WO2021007435A1 - Peptide conjugates of cytotoxins as therapeutics - Google Patents
WO2021007435A1 - Peptide conjugates of cytotoxins as therapeutics - Google Patents …
WO2021007435A1 - Peptide conjugates of cytotoxins as therapeutics - Google Patents …
Investigation of cytotoxic activity of full-length and truncated colicin n on human cancer cells
M Duangkaew - 2020 - digital.car.chula.ac.th
Bacteria, exposed to stress from the environment or competition, release toxins called
bacteriocins. Bacteriocins are classified by their mode of cytotoxicity such as pore former …
bacteriocins. Bacteriocins are classified by their mode of cytotoxicity such as pore former …
Nucleic acid assemblies for use in targeted delivery
the disclosed invention is generally in the field of nucleic acid assemblies and specifically in
the area of nucleic acid assemblies for targeting cargo to cells, tissues, organs, and …
the area of nucleic acid assemblies for targeting cargo to cells, tissues, organs, and …
Development of self-eliminating linkers for drug conjugates
SL Nergård - 2018 - munin.uit.no
Newly discovered compounds through bioprospecting are screened for cytotoxicity, and
many of them are found to be highly toxic. Because they are often not specifically toxic only …
many of them are found to be highly toxic. Because they are often not specifically toxic only …